Skip to main content
Top
Published in: Urolithiasis 2/2019

Open Access 01-04-2019 | Original Paper

Journey of a cystinuric patient with a long-term follow-up from a medical stone clinic: necessity to be SaFER (stone and fragments entirely removed)

Authors: Sacha L. Moore, Bhaskar K. Somani, Paul Cook

Published in: Urolithiasis | Issue 2/2019

Login to get access

Abstract

There is a lack of studies looking at the longitudinal follow-up of patients with cystine stones. We wanted to assess the journey of cystinuric patients through our specialist metabolic stone clinic to improve the understanding of episodes, interventions and current outcomes in this patient cohort. After ethical approval, all patients who attended our metabolic stone clinic from 1994 to 2014 with at least one cystine stone episode were included in our study. Data were retrospectively analysed for patient demographics, stone episodes or intervention, clinical parameters and patient compliance. Over a period of 21 years, 16 patients with a median age of 15.5 years underwent a mean follow-up of 8.6 years (1–21 years). The mean number of surgical interventions was 3.1 (1–8/patient), but patients who were stone free after their first treatment had lower recurrences (p = 0.91) and lower number of interventions during their follow-up (2.7/patient, compared to those who were not stone free at 4/patient). During their follow-up period, patients with < 3 interventions had a significantly better renal function than those with ≥ 3 surgical interventions (p = 0.04). Additionally, linear regression analysis showed that eGFR was demonstrated to decline with increasing numbers of stone episodes (r2 = 0.169). It was also noted that patients who began early medical management remained stone free during follow-up compared to those who had medical management after ≥ 2 stone episodes, of whom all had a recurrent episode. Our long-term longitudinal study of cystine stone formers highlights that patients who are stone free and receive early metabolic stone screening and medical management after their initial presentation have the lowest recurrence rates and tend to preserve their renal function. Hence, prompt referral for metabolic assessment, and the stone and fragments entirely removed (SaFER) principles are key to preventing stone episodes and improving long-term function.
Literature
1.
go back to reference Claes DJ, Jackson E (2012) Cystinuria: mechanisms and management. Pediatr Nephrol 27(11):2031–2038CrossRefPubMed Claes DJ, Jackson E (2012) Cystinuria: mechanisms and management. Pediatr Nephrol 27(11):2031–2038CrossRefPubMed
2.
go back to reference Saravakos P, Kokkinou V, Giannatos E (2014) Cystinuria: current diagnosis and management. Urology 83(4):693–699CrossRefPubMed Saravakos P, Kokkinou V, Giannatos E (2014) Cystinuria: current diagnosis and management. Urology 83(4):693–699CrossRefPubMed
3.
go back to reference Knoll T, Zollner A, Wendt-Nordahl G et al (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20(1):19–24CrossRefPubMed Knoll T, Zollner A, Wendt-Nordahl G et al (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20(1):19–24CrossRefPubMed
4.
go back to reference Sfoungaristos S, Hakim R, Katz R et al (2015) Cystine stones: a single tertiary center experience. J Endourol 29(3):362–366CrossRefPubMed Sfoungaristos S, Hakim R, Katz R et al (2015) Cystine stones: a single tertiary center experience. J Endourol 29(3):362–366CrossRefPubMed
5.
go back to reference Yamacake KG, Marchini GS, Reis S et al (2016) The challenge of cystine and struvite stone formers: clinical, metabolic and surgical assessment. Int Braz J Urol 42(5):977–985CrossRefPubMedPubMedCentral Yamacake KG, Marchini GS, Reis S et al (2016) The challenge of cystine and struvite stone formers: clinical, metabolic and surgical assessment. Int Braz J Urol 42(5):977–985CrossRefPubMedPubMedCentral
6.
go back to reference Thomas K, Wong K, Withington J et al (2014) Cystinuria-a urologist’s perspective. Nat Rev Urol 11(5):270–277CrossRefPubMed Thomas K, Wong K, Withington J et al (2014) Cystinuria-a urologist’s perspective. Nat Rev Urol 11(5):270–277CrossRefPubMed
8.
go back to reference Andreassen KH, Pedersen KV, Osther SS et al (2016) How should patients with cystine stone disease be evaluated and treated in the twenty-first century? Urolithiasis 44(1):65–76CrossRefPubMed Andreassen KH, Pedersen KV, Osther SS et al (2016) How should patients with cystine stone disease be evaluated and treated in the twenty-first century? Urolithiasis 44(1):65–76CrossRefPubMed
10.
go back to reference Fotiadis D, Kanai Y, Palacin M (2013) The SLC3 and SLC7 families of amino acid transporters. Mole Aspects Med 34(2–3):139–58CrossRef Fotiadis D, Kanai Y, Palacin M (2013) The SLC3 and SLC7 families of amino acid transporters. Mole Aspects Med 34(2–3):139–58CrossRef
11.
go back to reference Gaildrat P, Lebbah S, Tebani A et al (2017) Clinical and molecular characterization of cystinuria in a French cohort: relevance of assessing large-scale rearrangements and splicing variants. Mol Genet Genom Med 16(5):373–389CrossRef Gaildrat P, Lebbah S, Tebani A et al (2017) Clinical and molecular characterization of cystinuria in a French cohort: relevance of assessing large-scale rearrangements and splicing variants. Mol Genet Genom Med 16(5):373–389CrossRef
12.
go back to reference Wong KA, Mein R, Wass M et al (2015) The genetic diversity of cystinuria in a UK population of patients. BJU Int 116(1):109–116CrossRefPubMed Wong KA, Mein R, Wass M et al (2015) The genetic diversity of cystinuria in a UK population of patients. BJU Int 116(1):109–116CrossRefPubMed
13.
go back to reference Wong Y, Cook P, Roderick P et al (2016) Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol 30(3):246–253CrossRefPubMed Wong Y, Cook P, Roderick P et al (2016) Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol 30(3):246–253CrossRefPubMed
14.
go back to reference Young G, Kampantais S, Stasinou T et al (2017) Adherence of cystinuric patients to medical prevention treatment and its impact on clinical outcomes. Eur Urol Suppl 16(3):e19CrossRef Young G, Kampantais S, Stasinou T et al (2017) Adherence of cystinuric patients to medical prevention treatment and its impact on clinical outcomes. Eur Urol Suppl 16(3):e19CrossRef
15.
go back to reference Ahmed K, Khan MS, Thomas K et al (2008) Management of cystinuric patients: an observational, retrospective, single-centre analysis. Urol Int 80(2):141–144CrossRefPubMed Ahmed K, Khan MS, Thomas K et al (2008) Management of cystinuric patients: an observational, retrospective, single-centre analysis. Urol Int 80(2):141–144CrossRefPubMed
16.
go back to reference Shim M, Park HK (2014) Multimodal treatments of cystine stones: an observational, retrospective single-center analysis of 14 cases. Korean J Urol 55(8):515–519CrossRefPubMedPubMedCentral Shim M, Park HK (2014) Multimodal treatments of cystine stones: an observational, retrospective single-center analysis of 14 cases. Korean J Urol 55(8):515–519CrossRefPubMedPubMedCentral
17.
go back to reference Trinchieri A, Montanari E, Zanetti G (2007) The impact of new technology in the treatment of cystine stones. Urol Res 35(3):129–132CrossRefPubMed Trinchieri A, Montanari E, Zanetti G (2007) The impact of new technology in the treatment of cystine stones. Urol Res 35(3):129–132CrossRefPubMed
19.
go back to reference Streeper NM, Wertheim ML et al (2017) Cystine stone formers have impaired health-related quality of life compared with noncystine stone formers: case-referent study piloting the Wisconsin stone quality of life questionnaire among patients with cystine stones. J Endourol 31(S1):S48-S53CrossRefPubMed Streeper NM, Wertheim ML et al (2017) Cystine stone formers have impaired health-related quality of life compared with noncystine stone formers: case-referent study piloting the Wisconsin stone quality of life questionnaire among patients with cystine stones. J Endourol 31(S1):S48-S53CrossRefPubMed
20.
go back to reference Wright A, Rukin N, Smith D et al (2016) ‘Mini, Ultra, Micro’—Nomenclature and cost of these new minimally invasive nephrolithotomy (PCNL) techniques. Ther Adv Urol 8(2):146–146CrossRef Wright A, Rukin N, Smith D et al (2016) ‘Mini, Ultra, Micro’—Nomenclature and cost of these new minimally invasive nephrolithotomy (PCNL) techniques. Ther Adv Urol 8(2):146–146CrossRef
21.
go back to reference Somani BK, Robertson A, Kata SG (2011) Decreasing cost of flexible ureterorenoscopic procedures: cost volume relationship. Urology 78(3):528–530CrossRefPubMed Somani BK, Robertson A, Kata SG (2011) Decreasing cost of flexible ureterorenoscopic procedures: cost volume relationship. Urology 78(3):528–530CrossRefPubMed
22.
go back to reference Chapman RA, Somani BK, Robertson A, Healy S, Kata SG (2014) Decreasing cost of flexible ureterorenoscopy: single-use laser fiber cost analysis. Urology 83(5):1003–1005CrossRefPubMed Chapman RA, Somani BK, Robertson A, Healy S, Kata SG (2014) Decreasing cost of flexible ureterorenoscopy: single-use laser fiber cost analysis. Urology 83(5):1003–1005CrossRefPubMed
23.
go back to reference Pareek G, Steele TH, Nakada SY (2005) Urological intervention in patients with cystinuria is decreased with medical compliance. J Urol 174(6):2250–2252CrossRefPubMed Pareek G, Steele TH, Nakada SY (2005) Urological intervention in patients with cystinuria is decreased with medical compliance. J Urol 174(6):2250–2252CrossRefPubMed
24.
go back to reference Parr JM, Desai D, Winkle D (2015) Natural history and quality of life in patients with cystine urolithiasis: a single centre study. BJUI 116(S3):31–35CrossRef Parr JM, Desai D, Winkle D (2015) Natural history and quality of life in patients with cystine urolithiasis: a single centre study. BJUI 116(S3):31–35CrossRef
25.
go back to reference Tiselius HG (2010) New horizons in the management of patients with cystinuria. Curr Opin Urol 20(2):169–173CrossRefPubMed Tiselius HG (2010) New horizons in the management of patients with cystinuria. Curr Opin Urol 20(2):169–173CrossRefPubMed
26.
go back to reference Somani BK, Desai M, Traxer O, Lahme S (2014) Stone-free rate (SFR): a new proposal for defining levels of SFR. Urolithiasis 42(2):95CrossRefPubMed Somani BK, Desai M, Traxer O, Lahme S (2014) Stone-free rate (SFR): a new proposal for defining levels of SFR. Urolithiasis 42(2):95CrossRefPubMed
Metadata
Title
Journey of a cystinuric patient with a long-term follow-up from a medical stone clinic: necessity to be SaFER (stone and fragments entirely removed)
Authors
Sacha L. Moore
Bhaskar K. Somani
Paul Cook
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 2/2019
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-018-1059-5

Other articles of this Issue 2/2019

Urolithiasis 2/2019 Go to the issue